LLY

710.61

+0.3%↑

JNJ

179.04

+0.08%↑

ABBV

210.25

+0.41%↑

UNH

306.92

+1.28%↑

AZN

80.93

+0.65%↑

LLY

710.61

+0.3%↑

JNJ

179.04

+0.08%↑

ABBV

210.25

+0.41%↑

UNH

306.92

+1.28%↑

AZN

80.93

+0.65%↑

LLY

710.61

+0.3%↑

JNJ

179.04

+0.08%↑

ABBV

210.25

+0.41%↑

UNH

306.92

+1.28%↑

AZN

80.93

+0.65%↑

LLY

710.61

+0.3%↑

JNJ

179.04

+0.08%↑

ABBV

210.25

+0.41%↑

UNH

306.92

+1.28%↑

AZN

80.93

+0.65%↑

LLY

710.61

+0.3%↑

JNJ

179.04

+0.08%↑

ABBV

210.25

+0.41%↑

UNH

306.92

+1.28%↑

AZN

80.93

+0.65%↑

Search

Nektar Therapeutics

Chiusa

27.03 -3.01

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

26.79

Massimo

29.57

Metriche Chiave

By Trading Economics

Entrata

9.3M

-42M

Vendite

715K

11M

EPS

-2.78

Margine di Profitto

-372.197

Dipendenti

61

EBITDA

4.7M

-36M

Raccomandazioni

By TipRanks

Raccomandazioni

Acquista

Previsioni per 12 mesi

+243.46% upside

Dividendi

By Dow Jones

Utili prossimi

6 nov 2025

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

118M

522M

Apertura precedente

30.04

Chiusura precedente

27.03

Punteggio Tecnico

By Trading Central

Fiducia

Strong Bearish Evidence

Nektar Therapeutics Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

22 ago 2025, 23:09 UTC

Acquisizioni, Fusioni, Takeovers

Trump Says U.S. Will Take Nearly 10% Equity Stake in Intel -- 4th Update

22 ago 2025, 22:02 UTC

Acquisizioni, Fusioni, Takeovers

Agreement Could Also Lead to Deeper Collaboration Between CSX, BNSF

22 ago 2025, 22:02 UTC

Acquisizioni, Fusioni, Takeovers

Some Analysts Say Agreement Suggests Lack of Confidence in Merger

22 ago 2025, 22:02 UTC

Acquisizioni, Fusioni, Takeovers

CSX, BNSF Intermodal Pact Draws Competing Views on Merger Possibility

22 ago 2025, 22:02 UTC

Acquisizioni, Fusioni, Takeovers

CSX, BNSF Pact Sparks Debate on Whether Another Rail Merger Is Approaching -- Analysis

22 ago 2025, 22:02 UTC

Acquisizioni, Fusioni, Takeovers

Pact Could Show Regulators That Transcontinental Service Can Come Without Merger

22 ago 2025, 21:23 UTC

Discorsi di Mercato

Moody's Lowers Outlook on Austria to Negative From Stable -- Market Talk

22 ago 2025, 21:18 UTC

Discorsi di Mercato

US Economic Growth Seen Slowing This Year -- Market Talk

22 ago 2025, 21:18 UTC

Acquisizioni, Fusioni, Takeovers

U.S. Takes 10% Stake in Intel -- Barrons.com

22 ago 2025, 21:03 UTC

Discorsi di Mercato

Global Forex and Fixed Income Roundup: Market Talk

22 ago 2025, 21:03 UTC

Discorsi di Mercato

Mexican Stocks Close At Record High -- Market Talk

22 ago 2025, 20:58 UTC

Discorsi di Mercato

US General Government Deficit Expected to Rise in 2026, 2027 -- Market Talk

22 ago 2025, 20:57 UTC

Acquisizioni, Fusioni, Takeovers

Intel: Government's Investment in Intel Will Be a Passive Ownership, With No Bd Representation or Other Governance or Info Rights >INTC

22 ago 2025, 20:57 UTC

Acquisizioni, Fusioni, Takeovers

Intel: Government Also Agrees to Vote With the Company's Bd of Directors on Matters Requiring Shareholder Approval, With Limited Exceptions >INTC

22 ago 2025, 20:57 UTC

Acquisizioni, Fusioni, Takeovers

Intel: Government Equity Stake Will Be Funded by Remaining $5.7B in Grants Previously Awarded, But Not Yet Paid, Under U.S. CHIPS and Science Act and $3.2B Awarded as Part of Secure Enclave Program >INTC

22 ago 2025, 20:57 UTC

Acquisizioni, Fusioni, Takeovers

Intel: Government Agrees to Purchase 433.3M Primary Shrs of Intel Common Stk at a Price of $20.47 per Shr, Equivalent to a 9.9% Stake in Co >INTC

22 ago 2025, 20:57 UTC

Acquisizioni, Fusioni, Takeovers

Intel: U.S. Government to Make $8.9B Investment in Intel Common Stk as Co Builds Upon Its More Than $100B Expansion of Resilient Semiconductor Supply Chain >INTC

22 ago 2025, 20:57 UTC

Acquisizioni, Fusioni, Takeovers

Intel: Intel and Trump Admin Reach Historic Agreement to Accelerate Amer Technology and Manufacturing Leadership

22 ago 2025, 20:56 UTC

Utili

These Stocks Moved the Most Today: Nvidia, Builders FirstSource, Zoom, Intuit, Workday, BJ's, Ubiquiti, and More -- Barrons.com

22 ago 2025, 20:55 UTC

Utili

These Stocks Are Moving the Most Today: Nvidia, Builders FirstSource, Zoom, Intuit, Workday, BJ's, Ubiquiti, and More -- Barrons.com

22 ago 2025, 20:50 UTC

Discorsi di Mercato
Utili

Tech, Media & Telecom Roundup: Market Talk

22 ago 2025, 20:50 UTC

Discorsi di Mercato
Acquisizioni, Fusioni, Takeovers

Basic Materials Roundup: Market Talk

22 ago 2025, 20:41 UTC

Acquisizioni, Fusioni, Takeovers

U.S. Has 10% Stake in Intel, Lutnick Says -- Barrons.com

22 ago 2025, 20:24 UTC

Acquisizioni, Fusioni, Takeovers

Trump Says U.S. Will Take Nearly 10% Equity Stake in Intel -- 3rd Update

22 ago 2025, 20:16 UTC

Acquisizioni, Fusioni, Takeovers

CSX and Warren Buffett's BNSF Made News. Why Investors Are Disappointed. -- Barrons.com

22 ago 2025, 19:19 UTC

Discorsi di Mercato

Boeing to Restart Talks With Defense Workers' Union Monday -- Market Talk

22 ago 2025, 19:10 UTC

Discorsi di Mercato

Oil Futures Gain as Russia-Ukraine Peace Seems Distant -- Market Talk

22 ago 2025, 19:06 UTC

Discorsi di Mercato

U.S. Natural Gas Extends Losses as Summer Nears an End -- Market Talk

22 ago 2025, 19:03 UTC

Discorsi di Mercato

Lower Borrowing Rates Elusive Even if Fed Cuts -- Market Talk

22 ago 2025, 18:52 UTC

Acquisizioni, Fusioni, Takeovers

Trump Says U.S. Will Take Nearly 10% Equity Stake in Intel -- 2nd Update

Confronto tra pari

Modifica del prezzo

Nektar Therapeutics Previsione

Obiettivo di Prezzo

By TipRanks

243.46% in crescita

Previsioni per 12 mesi

Media 96.17 USD  243.46%

Alto 120 USD

Basso 69 USD

Basato su 8 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Nektar Therapeutics - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Acquista

8 ratings

6

Acquista

1

Mantieni

1

Vendi

Punteggio Tecnico

By Trading Central

0.5949 / 0.7406Supporto e resistenza

A breve termine

Strong Bearish Evidence

A termine intermedio

Strong Bearish Evidence

A lungo termine

Bearish Evidence

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$